InvestSMART

Aumake Limited (ASX:AUK)

ALERT: Price-sensitive ASX Announcement for AUK
Current share price for AUK : $0.003 0.001 (50%)+
Announcement
Release
30 Jan 2026 4:37PM
Price at Release
$0.002
Full Release
download
Summary
Aumake Limited reported positive operating cash flows of $316,000 for the quarter ending 31 December 2025, attributed to cost-cutting measures and a business rebasing process. Cash receipts were $2.6 million, reflecting reduced inventory investment during this period of operational restructuring. The company successfully entered the high-growth China OTC Medicine Market and raised $1.5 million from investors. Significant changes were made at the board level to enhance transparency and governance, including separating management from the board and appointing new directors with financial and legal expertise. This quarter was pivotal in Aumake's ongoing efforts to become a profitable and transparent business, leveraging its platform for sales in China. The AuMake China business unit generated $2 million in sales for the quarter and approximately $10 million for the half-year, while a new OTC Business line commenced sales with higher margin products. Operational challenges in the Global Business Unit led to a strategic review, and trading was paused to reassess funding and contractual obligations.
Key Points
  • Positive operating cash flows of $316,000 for the quarter.
  • Cash receipts fell to $2.6 million due to reduced inventory investment.
  • Entry into the high-growth China OTC Medicine Market.
  • Raised $1.5 million from sophisticated and institutional investors.
  • Major board changes to improve governance and transparency.
  • AuMake China business unit generated $2 million in sales for the quarter.
  • Introduction of a new OTC Business with higher margin products.
  • Operational and financial challenges in the Global Business Unit led to a review and temporary pause in trading.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.